說明表 1. | IGF-1 生物參考區間 | |||||||||||
性別 | Age(歲) | 參考值區間,ng/mL, (95%信賴區間) | 性別 | Age(歲) | 參考值區間,ng/mL, (95%信賴區間) | 性別 | Age(歲) | 參考值區間,ng/mL, (95%信賴區間) | 性別 | Age(歲) | 參考值區間,ng/mL, (95%信賴區間) | |
Male | 0-3 | <15 – 129 | Female | 0-3 | 18.2-172 | ALL | 19-21 | 117-323 | ALL | 50-54 | 48.1-209 | |
Male | 4-6 | 22-208 | Female | 4-6 | 35.4-232 | ALL | 22-24 | 98.7-289 | ALL | 55-59 | 44.7-210 | |
Male | 7-9 | 40.1-255 | Female | 7-9 | 35.9-277 | ALL | 25-29 | 83.6-259 | ALL | 60-64 | 43-220 | |
Male | 10-11 | 68.7-316 | Female | 10-11 | 118-448 | ALL | 30-34 | 71.2-234 | ALL | 65-69 | 40.2-225 | |
Male | 12-13 | 143-506 | Female | 12-13 | 170-527 | ALL | 35-39 | 63.4-223 | ALL | 70-79 | 35.1-216 | |
Male | 14-15 | 177-506 | Female | 14-15 | 191-496 | ALL | 40-44 | 58.2-219 | ALL | 80-90 | 30.6-208 | |
Male | 16-18 | 173-414 | Female | 16-18 | 190-429 | ALL | 45-49 | 53.3-215 | ||||
說明表2. | QantiFERON (IGRA) 生物參考區間-判別對照表 | |||||||||||
Nil(IU/mL)值 | TB Ag 減 Nil 值(IU/mL) | Mitogen 減 Nil 值(IU/mL) | 檢驗結果判讀 | 建議處置 | ||||||||
<=8.0 | >=0.35 及 >=25%Nil值 | 任何數值 | Positive | 轉介至LTBI治療合作醫師,進行治療評估 | ||||||||
<0.35 | >=0.5 | Negative | 無需轉介治療評估,衛教接觸者後續若有結核病症狀,應立即就醫 | |||||||||
>=0.35 及 >=25%Nil值 | >=0.5 | Negative | 無需轉介治療評估,衛教接觸者後續若有結核病症狀,應立即就醫 | |||||||||
<0.35 | <0.5 | 不確定(Mitogen<0.5) | 轉介至LTBI治療合作醫師,進行治療評估 | |||||||||
>=0.35 及 >=25%Nil值 | <0.5 | 不確定(Mitogen<0.5) | 轉介至LTBI治療合作醫師,進行治療評估 | |||||||||
>8.0 | 任何數值 | 任何數值 | 不確定 | 請安排接觸者再次抽血檢驗
|
說明表3. | C3補體生物參考區間(mg/dL) | |
Age | 參考區間 | |
Newborns | 58-108 | |
3個月 | 67-124 | |
6個月 | 74-138 | |
9個月 | 78-144 | |
12個月 | 80-150 | |
2-10歲 | 80-150 | |
12-18歲 | 85-160 | |
20歲 | 82-160 | |
30歲 | 84-160 | |
40-70歲 | 90-170 |
說明表4. | DHEA-S 生物參考區間(μg/dL) | |||||||
性別 | Age(歲) | 參考值區間 | 性別 | Age(歲) | 參考值區間 | 性別 | Age(歲) | 參考值區間 |
Female | 10-14 | 33.9-280 | Male | 10-14 | 24.4-247 | ALL | <1 weeks | 108-607 |
Female | 15-19 | 65.1-368 | Male | 15-19 | 70.2-492 | ALL | 1-4 weeks | 31.6-431 |
Female | 20-24 | 148-407 | Male | 20-24 | 211-492 | ALL | 1-12 Mos. | 3.4-124 |
Female | 25-34 | 98.8-340 | Male | 25-34 | 160-449 | ALL | 1-4 years | 0.47-19.4 |
Female | 35-44 | 60.9-337 | Male | 35-44 | 88.9-427 | ALL | 5-10 years | 2.8-85.2 |
Female | 45-54 | 35.4-256 | Male | 45-54 | 44.3-331 | |||
Female | 55-64 | 18.9-205 | Male | 55-64 | 51.7-295 | |||
Female | 65-74 | 9.4-246 | Male | 65-74 | 33.6-249 | |||
Female | >75 | 12-154 | Male | >75 | 16.2-123 |
【重要消息】和信醫院提供疫苗接種服務
|